G
GRAIL
Menlo Park, CA
HealthSeries D🚀 Hot🦄 Unicorn
Total Raised
$390M
Valuation
$3.2B
GRAIL develops multi-cancer early detection blood tests using genomic sequencing and machine learning.
Funding Details
| Round | Series D |
| Amount | $390M |
| Valuation | $3.2B |
| Date | May 2020 |
| Stage | series-d |
| Headquarters | Menlo Park, CA |
Investors
Bristol-Myers SquibbJohnson & JohnsonMerck
Signal
🚀
🚀 HotHot — $100M+ round